Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)
China · Delayed Price · Currency is CNY 18.04
+0.24 (1.35%)
May 29, 2026, 3:00 PM CST
SHA:605266 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 150.57 | 148.15 | 128.13 | 414.41 | 374.29 | 300.53 |
Depreciation & Amortization | 804.24 | 804.24 | 828.66 | 748.65 | 609.74 | 481.72 |
Other Amortization | 163.9 | 163.9 | 152.39 | 129.83 | 102.75 | 65.63 |
Loss (Gain) From Sale of Assets | -6.17 | -6.17 | -7.26 | -10.02 | 1.09 | -0.19 |
Asset Writedown & Restructuring Costs | 34.52 | 34.52 | 11.01 | 4.93 | 34.93 | - |
Loss (Gain) From Sale of Investments | 7.46 | 7.46 | 9.1 | 7.94 | -0.31 | -5.96 |
Provision & Write-off of Bad Debts | 21.44 | 21.44 | 1.77 | -1.46 | 4.38 | 0.59 |
Other Operating Activities | 133.87 | 154.28 | 172.13 | 148.25 | 103.13 | 65.54 |
Change in Accounts Receivable | -623.75 | -623.75 | -79.02 | 161.57 | -311.86 | -89.8 |
Change in Inventory | 985.03 | 985.03 | -784.21 | -229.67 | -751.97 | -367.59 |
Change in Accounts Payable | -512.94 | -512.94 | 66.39 | -358.87 | 1,048 | 280.98 |
Change in Other Net Operating Assets | - | - | 21.79 | 0.65 | 4.51 | 13.96 |
Operating Cash Flow | 1,152 | 1,170 | 508.98 | 1,024 | 1,191 | 744.4 |
Operating Cash Flow Growth | 95.88% | 129.85% | -50.31% | -13.96% | 59.94% | 135.10% |
Capital Expenditures | -117.2 | -144.56 | -267.92 | -300.04 | -780.68 | -385.53 |
Sale of Property, Plant & Equipment | 24.08 | 24.16 | 0.11 | 0.31 | 2.4 | 0.02 |
Cash Acquisitions | - | - | -464.42 | -129.85 | -1,707 | -321.18 |
Investment in Securities | -11.39 | 48.62 | 7.45 | -99.6 | -15.72 | -23.8 |
Other Investing Activities | 0.51 | 0.5 | 0.34 | 6.65 | 1.86 | 6.32 |
Investing Cash Flow | -104 | -71.29 | -724.45 | -522.54 | -2,499 | -724.17 |
Short-Term Debt Issued | - | 1,542 | 1,030 | 427.76 | 29.08 | - |
Long-Term Debt Issued | - | 1,321 | 1,471 | 488.05 | 1,540 | 30 |
Total Debt Issued | 2,899 | 2,863 | 2,501 | 915.82 | 1,569 | 30 |
Short-Term Debt Repaid | - | -1,449 | -768.39 | -235.93 | - | - |
Long-Term Debt Repaid | - | -2,029 | -1,471 | -1,137 | -669.12 | -591.64 |
Total Debt Repaid | -3,627 | -3,478 | -2,240 | -1,373 | -669.12 | -591.64 |
Net Debt Issued (Repaid) | -728.45 | -615.06 | 260.99 | -456.99 | 900.24 | -561.64 |
Issuance of Common Stock | - | - | 43.84 | - | 413.5 | 25.75 |
Repurchase of Common Stock | -135.75 | -135.75 | -54 | - | - | -0.34 |
Common Dividends Paid | -245.84 | -242.9 | -241.86 | -204.92 | -155.04 | -124.03 |
Other Financing Activities | 35.38 | -3.61 | -3.54 | -1.18 | -2.54 | -5.52 |
Financing Cash Flow | -1,075 | -997.31 | 5.43 | -663.09 | 1,156 | -665.78 |
Foreign Exchange Rate Adjustments | -1.88 | -1.73 | -0.24 | - | - | - |
Net Cash Flow | -28.64 | 99.57 | -210.28 | -161.22 | -151.88 | -645.55 |
Free Cash Flow | 1,035 | 1,025 | 241.05 | 724.37 | 409.93 | 358.87 |
Free Cash Flow Growth | 197.97% | 325.36% | -66.72% | 76.71% | 14.23% | 95.50% |
Free Cash Flow Margin | 11.87% | 11.49% | 2.60% | 7.98% | 5.46% | 6.86% |
Free Cash Flow Per Share | 7.01 | 6.92 | 1.56 | 4.68 | 2.70 | 2.57 |
Cash Income Tax Paid | 295.24 | 269.89 | 432.72 | 330.98 | 130.31 | 113.56 |
Levered Free Cash Flow | 860.64 | 734.68 | 136.56 | 545.49 | 164.35 | 406.79 |
Unlevered Free Cash Flow | 934.2 | 810.13 | 221.17 | 621.26 | 226.8 | 437.91 |
Change in Working Capital | -157.91 | -157.91 | -786.95 | -418.12 | -39.39 | -163.46 |